US Patent Issued to HALO Therapeutics on Aug. 25 for "Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor" (Ukrainian, Swiss Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,867, issued on Aug. 25, was assigned to HALO Therapeutics Ltd (Caerphilly, Great Britain).

"Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor" was invented by Mikhail Shafeev (Kyiv, Ukraine), Daniel Josef Fitzgerald (Carouge, Switzerland), Dominik Wolfgang Schelshorn (Geneva) and Igor I. Pervak (Kyiv, Ukraine).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel free fatty acid receptor (FFAR) agonists, in particular agonists of FFAR1, and the use of said FFAR agonists as medicaments, in particular for treatment and/or prevention of conditions or diseases amenable to enhanced activity of FFAR1 such as cond...